Evidence map›Paper›PMID 32669684›Full record

ArticleNature chemical biology2020

Author Correction: The bottromycin epimerase BotH defines a group of atypical α/β-hydrolase-fold enzymes.

Asfandyar Sikandar, Laura Franz, Sebastian Adam, Javier Santos-Aberturas, Liliya Horbal, Andriy Luzhetskyy, Andrew W Truman, Olga V Kalinina, Jesko Koehnke

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Asfandyar Sikandar *Workgroup Structural Biology of Biosynthetic Enzymes, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University, Saarbrücken, Germany.
Laura Franz *Workgroup Structural Biology of Biosynthetic Enzymes, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University, Saarbrücken, Germany.ORCID http://orcid.org/0000-0003-1649-3375
Sebastian AdamWorkgroup Structural Biology of Biosynthetic Enzymes, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University, Saarbrücken, Germany.
Javier Santos-AberturasDepartment of Molecular Microbiology, John Innes Centre, Norwich, UK.ORCID http://orcid.org/0000-0002-6689-8111
Liliya HorbalDepartment of Microbial Natural Products, Actinobacteria Metabolic Engineering Group, HIPS, HZI, Saarland University, Saarbrücken, Germany.
Andriy LuzhetskyyDepartment of Microbial Natural Products, Actinobacteria Metabolic Engineering Group, HIPS, HZI, Saarland University, Saarbrücken, Germany.
Andrew W TrumanDepartment of Molecular Microbiology, John Innes Centre, Norwich, UK.ORCID http://orcid.org/0000-0001-5453-7485
Olga V KalininaDrug Bioinformatics Group, HIPS, HZI, Saarland University, Saarbrücken, Germany.
Jesko KoehnkeWorkgroup Structural Biology of Biosynthetic Enzymes, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Centre for Infection Research (HZI), Saarland University, Saarbrücken, Germany. jesko.koehnke@glasgow.ac.uk.ORCID http://orcid.org/0000-0002-7153-1365

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32669684

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.